Are you looking for creative ways to reach and engage your healthcare audience?
Partner with medwireNews and see how our content and tactics can boost your independent educational activities to optimize your goals.
Specialists in medical education and content creation, we provide solutions that grab the attention of healthcare professionals and inform them on key messages in convenient, easily accessible and timely formats.
Our services can help you build trusted relationships with your healthcare professional audience by supporting them in the knowledge they need to stay up to date and ensure the continued learning essential to improving patient care.
- 25-04-2024|
- |
- Endocrinology |
Sampling lateralization affects BIPSS accuracy for diagnosing CD
Low lateralization may reduce the diagnostic accuracy of bilateral inferior petrosal sinus sampling for distinguishing Cushing’s disease from ectopic adrenocorticotropic hormone (ACTH) secretory syndrome, suggests a study published in the Journal of the Endocrine Society in March 2024.
- 25-04-2024|
- |
- Neurology |
- Paediatrics |
‘No substantive increase’ in ASD with prenatal topiramate exposure
Children born to women with epilepsy who take topiramate during the second half of their pregnancy do not have a substantially increased risk of autism spectrum disorder, suggests research published in The New England Journal of Medicine.
- 18-04-2024|
- |
- Oncology |
- Paediatrics |
Sepsis during paediatric leukaemia therapy linked to long-term neurocognitive dysfunction
Severe sepsis during treatment for childhood leukaemia may be associated with an increased risk of moderate-to-severe neurocognitive dysfunction in adulthood, US Study findings indicate.
- 10-04-2024|
- |
- Paediatrics |
Umbilical hernia repair ‘should be delayed’ until after age 5 years
The majority of umbilical hernias close spontaneously regardless of size, US researchers have found.
- 08-04-2024|
EV-302 results ‘a leap forward’ for advanced urothelial carcinoma
Phase 3 trial findings demonstrate a significant improvement in overall survival for patients with treatment-naïve, advanced urothelial carcinoma who receive a combination of enfortumab vedotin and pembrolizumab compared with chemotherapy.
- 27-03-2024|
- |
- Rheumatology |
CAR T cells show promise for treatment of autoimmune diseases
CD19 chimeric antigen receptor T-cell therapy appears to be “feasible, safe, and efficacious” for the treatment of three autoimmune diseases, researchers report.
- Oncology
- Conference Coverage & Reporting
- Rheumatology
- Featured Content Creation
- Diabetes
- Featured Content Creation
- Oncology
- Expert Interviews & Discussion
- Oncology
- Conference Coverage & Reporting
- Gastroenterology
- Conference Coverage & Reporting
- Rheumatology
- Expert Interviews & Discussion
- Rheumatology
- Conference Coverage & Reporting